Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis

NCT01719159 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Progressive Multiple Sclerosis

Interventions

DRUG: Rituximab

Sponsor

Anders Svenningsson

Collaborators

[object Object]